Raymond J. Henley Iii

Array ( [id] => 8159037 [patent_doc_number] => 20120100529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Biological Specimen Collection and Transport System and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/332204 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16081 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100529.pdf [firstpage_image] =>[orig_patent_app_number] => 13332204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817795 [patent_doc_number] => 08927580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Thiosemicarbazone compounds and use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/994355 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14098 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339627 [patent_doc_number] => 20140066409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'CYCLOHEXANE COMPOUNDS AND THEIR USE AS ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 13/990801 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17050 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141675 [patent_doc_number] => 20120095388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'MATERIAL FOR FACILITATING THERMAL TREATMENTS OF BIOLOGICAL TISSUES AND METHOD OF ENERGY TARGETING LEADING TO THERMAL TREATMENT OF BIOLOGICAL TISSUES' [patent_app_type] => utility [patent_app_number] => 13/311025 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11972 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095388.pdf [firstpage_image] =>[orig_patent_app_number] => 13311025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483121 [patent_doc_number] => 08729073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => '5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics' [patent_app_type] => utility [patent_app_number] => 13/991267 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6175 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9069392 [patent_doc_number] => 20130261148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'PROTECTED ANTIMICROBIAL COMPOUNDS FOR HIGH TEMPERATURE APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/993523 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2964 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8053997 [patent_doc_number] => 20120076733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'POST-BIOPSY CAVITY TREATMENT IMPLANTS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/309504 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16112 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076733.pdf [firstpage_image] =>[orig_patent_app_number] => 13309504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312514 [patent_doc_number] => 20120189537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/302409 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14799 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043417 [patent_doc_number] => 20120071446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 13/302881 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4940 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071446.pdf [firstpage_image] =>[orig_patent_app_number] => 13302881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192139 [patent_doc_number] => 20130331454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'PKC-EPSILON ACTIVATOR' [patent_app_type] => utility [patent_app_number] => 13/885751 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12836 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191010 [patent_doc_number] => 20130330326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'METHODS OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/884842 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 22189 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9149091 [patent_doc_number] => 20130303614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'AGENT FOR INHIBITING ELEVATION IN BLOOD GLUCOSE LEVEL' [patent_app_type] => utility [patent_app_number] => 13/884089 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4414 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199502 [patent_doc_number] => 20120122922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'COMPOSITIONS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 13/290491 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8010 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122922.pdf [firstpage_image] =>[orig_patent_app_number] => 13290491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171389 [patent_doc_number] => 20120107404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Crystalline Pharmaceutical and Methods of Preparation and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/289172 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 57361 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107404.pdf [firstpage_image] =>[orig_patent_app_number] => 13289172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10648206 [patent_doc_number] => 09364430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol' [patent_app_type] => utility [patent_app_number] => 13/882370 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 133867 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11242585 [patent_doc_number] => 09468612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-18 [patent_title] => 'Cysteamine in the treatment of fibrotic disease' [patent_app_type] => utility [patent_app_number] => 14/353273 [patent_app_country] => US [patent_app_date] => 2011-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 17826 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677032 [patent_doc_number] => 08815942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease' [patent_app_type] => utility [patent_app_number] => 13/277942 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 46 [patent_no_of_words] => 17130 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375812 [patent_doc_number] => 08680076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Methods of treatment, improvement and prevention using haloaryl substituted aminopurines' [patent_app_type] => utility [patent_app_number] => 13/277282 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28385 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9538461 [patent_doc_number] => 20140163108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/111442 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6647 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10528990 [patent_doc_number] => 09255118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Light induced drug release' [patent_app_type] => utility [patent_app_number] => 13/880253 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 19179 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880253 [rel_patent_id] =>[rel_patent_doc_number] =>)